BEVERLY HILLS, Calif., Sept. 25, 2009 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc. (OTCBB:TOMZ), the Professional Air Remediation Company, which has safely harnessed one of the most powerful disinfectants known to man, ozone, undertook the first of a nationwide series of training programs, under the personal direction of TOMI Founder and CEO Dr. Halden Shane, Tuesday, September 22, 2009, at Rolyn's headquarters in Rockville, MD. Rolyn, for the last thirty years, provides disaster response, recovery, restoration and compliance services to clients throughout the continental United States.
Dr. Shane reported that the 24 technicians are now proficient in the application of using Ultra-Violet Ozone for indoor elimination of disease-bearing pathogens, including swine flu (H1N1 virus), inactivating other viruses, killing bacteria, and mold spores, asthma triggers, allergens, and odors, in indoor environments. "This first group of now highly-trained technicians are able to utilize all of TOMI's products, including our UV-propriety, by-product free, ozone generators that produce pure ozone applied in unoccupied spaces; our Ultra-D disinfectant, which uses a mist of hydroxyl radicals to decontaminate small and medium size spaces in under an hour; the monster UVGI Terminator, and our custom Filtration device, which are able to control and prevent further and future decontamination in all structures, while reducing energy and coil cleaning cost in HVAC systems. Rolyn Companies has been very important in the introduction of our products and services to the certified remediation industry. When TOMI(ES) Ozone Deep Cleaning is provided using TOMI's next-generation clean ultraviolet ozone generators, the indoor air quality improvement is dramatic."
About TOMI Environmental Solutions, Inc. (TOMI(ES))
TOMI Environmental Solutions, Inc. (OTCBB:TOMZ) is a leading provider of unique environmental services that are revolutionizing the way people worldwide will achieve a safe and healthy indoor environment. The Company owns and operates state-of-the-art, proprietary Ultraviolet Ozone (UV) Generators that produce one of the most powerful oxidizers and disinfectants available: ozone. TOMI(ES) inspects, tests (on a DNA level) and treats indoor air using highly trained, certified technicians who are qualified to assess the air quality of homes, offices, or vehicles and to clean up the pollution. Compared to other existing methods of air purification, The TOMI(ES) system produces byproduct-free ozone with a high degree of safety and industry expertise. Additionally, to help maintain the clean environment after its deep cleaning, The Company offers its non-ozone producing UV germicidal accessories, the "Terminator" and "Silver Germicidal," that can be portable or permanently installed to maintain clean inside air. For more information, visit www.tomiesinc.com.
About Rolyn Companies, Inc:
For over thirty years, Rolyn has been providing disaster recovery, restoration and compliance services to clients of all sizes and industries. Headquartered in Rockville, Maryland, Rolyn provides disaster response services throughout the continental United States.
"Safe Harbor" Statement Under The Private Securities Litigation Reform Act Of 1995
Certain written and oral statements made by us may constitute "forward-looking statements" as defined in the Private Securities Litigation Reform Act of 1995 (the "Reform Act"). Forward-looking statements are identified by such words and phrases as "we expect," "expected to," "estimates," "estimated," "current outlook," "we look forward to," "would equate to," "projects," "projections," "projected to be," "anticipates," "anticipated," "we believe," "could be," and other similar phrases. All statements addressing operating performance, events, or developments that we expect or anticipate will occur in the future, including statements relating to revenue growth, earnings, earnings-per-share growth, or similar projections, are forward-looking statements within the meaning of the Reform Act. Because they are forward-looking, they should be evaluated in light of important risk factors that could cause our actual results to differ materially from our anticipated results. The information provided in this document is based upon the facts and circumstances known at this time. We undertake no obligation to update these forward-looking statements after the date of this release.